Bailard’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-36,508
Closed -$1.18M – 754
2026
Q2
$1.18M Buy
+36,508
New +$942K 0.02% 325
2023
Q3
– Sell
-2,088
Closed -$228K – 702
2023
Q2
$228K Buy
+2,088
New +$198K 0.01% 598
2023
Q1
– Sell
-2,000
Closed -$206K – 715
2022
Q4
$206K Sell
2,000
-3,600
-64% -$415K 0.01% 649
2022
Q3
$593K Buy
5,600
+1,000
+22% +$110K 0.02% 321
2022
Q2
$505K Buy
+4,600
New +$455K 0.02% 377
2022
Q1
– Sell
-2,730
Closed -$334K – 721
2021
Q4
$334K Sell
2,730
-2,601
-49% -$289K 0.01% 506
2021
Q3
$612K Hold
5,331
– – 0.02% 370
2021
Q2
$517K Buy
+5,331
New +$463K 0.02% 404

Other funds holding AMN

Bailard's AMN Position: Q3 2026 in Review

Bailard sold out of AMN Healthcare (AMN) in Q3 2026, closing a stake of 36,508 shares — an estimated $1.18M sold.

Bailard first reported a position in AMN in Q2 2021 and held it in 8 quarters. The position peaked at $1.18M in Q2 2026. 29 funds tracked by Wall St. Rank hold AMN as of Q3 2026.

  • Bailard reported no remaining AMN Healthcare position as of Q3 2026 after selling out during the quarter.
  • Bailard sold 36,508 AMN Healthcare shares in Q3 2026, an estimated $1.18M.
  • Bailard first reported a position in AMN Healthcare in Q2 2021 and held it in 8 quarters.
  • Bailard's AMN Healthcare position peaked at $1.18M in Q2 2026.
  • 29 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.